全文获取类型
收费全文 | 1945篇 |
免费 | 270篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 85篇 |
妇产科学 | 157篇 |
基础医学 | 278篇 |
口腔科学 | 38篇 |
临床医学 | 198篇 |
内科学 | 328篇 |
皮肤病学 | 30篇 |
神经病学 | 185篇 |
特种医学 | 70篇 |
外科学 | 175篇 |
综合类 | 44篇 |
预防医学 | 254篇 |
眼科学 | 66篇 |
药学 | 180篇 |
肿瘤学 | 125篇 |
出版年
2021年 | 25篇 |
2018年 | 29篇 |
2017年 | 27篇 |
2015年 | 27篇 |
2014年 | 44篇 |
2013年 | 64篇 |
2012年 | 44篇 |
2011年 | 64篇 |
2010年 | 47篇 |
2009年 | 61篇 |
2008年 | 70篇 |
2007年 | 65篇 |
2006年 | 62篇 |
2005年 | 52篇 |
2004年 | 58篇 |
2003年 | 58篇 |
2002年 | 60篇 |
2001年 | 51篇 |
2000年 | 43篇 |
1999年 | 49篇 |
1998年 | 35篇 |
1997年 | 51篇 |
1996年 | 46篇 |
1995年 | 36篇 |
1994年 | 36篇 |
1993年 | 33篇 |
1992年 | 30篇 |
1991年 | 45篇 |
1990年 | 38篇 |
1989年 | 39篇 |
1988年 | 39篇 |
1987年 | 31篇 |
1986年 | 48篇 |
1985年 | 53篇 |
1984年 | 23篇 |
1983年 | 25篇 |
1982年 | 24篇 |
1980年 | 30篇 |
1979年 | 34篇 |
1978年 | 30篇 |
1977年 | 29篇 |
1976年 | 24篇 |
1975年 | 30篇 |
1974年 | 38篇 |
1973年 | 34篇 |
1972年 | 38篇 |
1971年 | 36篇 |
1970年 | 25篇 |
1969年 | 23篇 |
1968年 | 31篇 |
排序方式: 共有2218条查询结果,搜索用时 0 毫秒
991.
Nature and functional implications of the cytochrome a3 transients after photodissociation of CO-cytochrome oxidase. 总被引:3,自引:3,他引:3 下载免费PDF全文
W H Woodruff O Einarsdóttir R B Dyer K A Bagley G Palmer S J Atherton R A Goldbeck T D Dawes D S Kliger 《Proceedings of the National Academy of Sciences of the United States of America》1991,88(6):2588-2592
Time-resolved electronic absorption, infrared, resonance Raman, and magnetic circular dichroism spectroscopies are applied to characterization of the intermediate that is formed within 20 ps after photodissociation of CO from cytochrome a3 in reduced cytochrome oxidase. This intermediate decays with the same half-life (approximately 1 microseconds) as the post-photodissociation CU+B-CO species previously observed by time-resolved infrared. The transient UV/visible spectra, kinetics, infrared, and Raman evidence suggest that an endogenous ligand is transferred from CuB to Fea3 when CO binds to CuB, forming a cytochrome a3 species with axial ligation that differs from the reduced unliganded enzyme. The time-resolved magnetic circular dichroism results suggest that this transient is high-spin and, therefore, five-coordinate. Thus we infer that the ligand from CuB binds on the distal side of cytochrome a3 and displaces the proximal histidine imidazole. This remarkable mechanistic feature is an additional aspect of the previously proposed "ligand-shuttle" activity of the CuB/Fea3 pair. We speculate as to the identity of the ligand that is transferred between CuB and Fea3 and suggest that the ligand shuttle may play a functional role in redox-linked proton translocation by the enzyme. 相似文献
992.
993.
M. S. Karpeh M. F. Brennan W. G. Cance J. M. Woodruff D. Pollack E. S. Casper M. E. Dudas E. Latres M. Drobnjak C. Cordon-Cardo 《British journal of cancer》1995,72(4):986-991
Altered expression of the retinoblastoma (RB) tumour-suppressor gene product (pRB) has been detected in sporadic bone and soft-tissue sarcomas. Earlier studies, analysing small cohorts of sarcoma patients, have suggested that these alterations are more commonly associated with high-grade tumours, metastatic lesions and poorer survival. This study was designed to re-examine the prevalence and clinical significance of altered pRB expression in a large and selected group of soft-tissue sarcomas from 174 adult patients. Representative tissue sections from these sarcomas were analysed by immunohistochemistry using a well-characterised anti-pRB monoclonal antibody. Tumours were considered to have a positive pRB phenotype only when pure nuclear staining was demonstrated, and cases were segregated into one of three groups. Group 1 (n = 36) were patients whose tumours have minimal or undetectable pRB nuclear staining (< 20% of tumour cells) and were considered pRB negative. Patients with tumours staining in a heterogeneous pattern (20-79% of tumour cells) were classified as group 2 (n = 99). The staining of group 3 (n = 39) was strongly positive with a homogeneous pRB nuclear immunoreactivity (80-100% of tumour cells). pRB alterations were frequently observed in both low- and high-grade lesions. Altered pRB expression did not correlate with known predictors of survival and was not itself an independent predictor of outcome in the long-term follow-up. These findings support earlier observations that alterations of pRB expression are common events in soft-tissue sarcomas; nevertheless, long-term follow-up results indicate that altered patterns of pRB expression do not influence clinical outcome of patients affected with soft-tissue sarcomas. It is postulated that RB alterations are primary events in human sarcomas and may be involved in tumorigenesis or early phases of tumour progression in these neoplasias. 相似文献
994.
Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements. 总被引:6,自引:0,他引:6
C R Antonescu A Elahi J H Healey M F Brennan M Y Lui J Lewis S C Jhanwar J M Woodruff M Ladanyi 《Clinical cancer research》2000,6(7):2788-2793
Multifocal presentation, defined as the presence of tumor at two or more anatomically separate sites, before the manifestation of disease in sites where sarcomas usually metastasize (e.g., lungs) occurs in about 1% of extremity soft tissue sarcomas (STSs). Debate still persists whether multifocal STSs represent an unusual pattern of metastasis or multiple separate primary tumors. Among STSs with multifocal presentation, myxoid liposarcoma is the predominant histological type. This subtype of liposarcoma contains the specific t(12;16) chromosomal translocation, which results in rearrangement of the TLS and CHOP genes that is clone specific at the DNA level. We, therefore, sought to address the question of clonality by molecular analysis in six patients who presented with either synchronous or metachronous multifocal myxoid liposarcoma. In all six cases, adequate frozen tumor was available for DNA extraction from at least two distinct anatomical sites. Southern blot analysis using CHOP, TLS, and EWS cDNA probes was performed on genomic DNA. Five cases contained a TLS-CHOP rearrangement, and one case had the variant EWS-CHOP fusion (seen in <5% of cases). The size of the rearranged CHOP fragment differed among the six patients, as expected, but was identical in all anatomically separate tumor samples from each patient. Likewise, the sizes of the rearranged bands observed with either the TLS or EWS probes supported the monoclonality of all cases. Our results confirm the monoclonal origin of multifocal myxoid liposarcoma, establishing the metastatic nature of distant soft tissue lesions in these cases. It remains unclear whether this unusual pattern of metastasis represents an intrinsic property of this subset of myxoid liposarcoma or merely a rare chance occurrence. The clinical outcomes observed in this small series suggest that the prognosis of multifocal myxoid liposarcoma is poor, regardless of its often bland or "low-grade" histological appearance. 相似文献
995.
Cristina R Antonescu Gunhild Sommer Lisa Sarran Sylvia J Tschernyavsky Elyn Riedel James M Woodruff Mark Robson Robert Maki Murray F Brennan Marc Ladanyi Ronald P DeMatteo Peter Besmer 《Clinical cancer research》2003,9(9):3329-3337
PURPOSE: Activating mutations of the KIT juxtamembrane region are the most common genetic events in gastrointestinal stromal tumors (GISTs) and have been noted as independent prognostic factors. The impact of KIT mutation in other regions, such as the extracellular or kinase domains, is not well-defined and fewer than 30 cases have been published to date. EXPERIMENTAL DESIGN: One hundred twenty GISTs, confirmed by KIT immunoreactivity, were evaluated for the presence of KIT exon 9, 11, 13, and 17 mutations. The relation between the presence/type of KIT mutation and clinicopathological factors was analyzed using Fisher's exact test and log-rank test. RESULTS: Forty-four % of the tumors were located in the stomach, 47% in the small bowel, 6% in the rectum, and 3% in the retroperitoneum. Overall, KIT mutations were detected in 78% of patients as follows: 67% in exon 11, 11% in exon 9, and none in exon 13 or 17. The types of KIT exon 11 mutations were heterogeneous and clustered in the classic "hot spot" at the 5' end of exon 11. Seven % of cases showed internal tandem duplications (ITD) at the 3' end of exon 11, in a region that we designate as a second hot spot for KIT mutations. Interestingly, these cases were associated with: female predominance, stomach location, occurrence in older patients, and favorable outcome. There were significant associations between exon 9 mutations and large tumor size (P < 0.001) and extragastric location (P = 0.02). Ten of these 13 patients with more than 1-year follow-up have developed recurrent disease. CONCLUSIONS: Most KIT-expressing GISTs show KIT mutations that are preferentially located within the classic hot spot of exon 11. In addition, we found an association between a second hot spot at the 3'end of exon 11, characterized by ITDs, and a subgroup of clinically indolent gastric GISTs in older females. KIT exon 9 mutations seem to define a distinct subset of GISTs, located predominantly in the small bowel and associated with an unfavorable clinical course. 相似文献
996.
Michael Morgan Andrew C. Bulmer Trent M. Woodruff Lavinia M. Proctor Hua M. Williams Shelli Z. Stocks Sandra Pollitt Stephen M. Taylor Ian A. Shiels 《European journal of pharmaceutical sciences》2008,33(4-5):390-398
Pharmacokinetics of the orally active, cyclic peptide complement factor C5a receptor antagonist, AcF-[OP(d-Cha)WR] (PMX53) were determined in the rat. Biliary excretion of the unchanged drug was a major route of elimination after intravenous administration, but not following oral administration. Portal and peripheral blood levels of PMX53 were determined after oral administration or direct injection into the ileum, colon or local administration into the rectum. PMX53 was rapidly absorbed from mucosal sites, with peak plasma levels occurring as early as 5 min post-administration. Early portal blood levels were consistently higher than peripheral levels following ileal, colonic and rectal administration, but not after oral dosing. The results suggest that hepatic elimination occurs rapidly with higher (≥100 ng/ml) peripheral blood levels of the drug. Combination of PMX53 with the excipient chitosan resulted in significantly higher peripheral levels of the drug following ileal and colonic application, but not with buccal or oral administration. Buccal administration resulted in a similar plasma pharmacokinetic profile to oral administration. These results suggest that PMX53 is rapidly absorbed across mucosal membranes in the rat, and that administration using excipients such as chitosan may offer a method of increasing bioavailability. 相似文献
997.
998.
Commentary on E. Berkery,S. Tiernan and M. Morley (2014) The relationship between gender role stereotypes and requisite managerial characteristics: the case of nursing and midwifery professionals 下载免费PDF全文
Joan Lalor PhD MA MSc PG Diploma in Stats CHSE BNS 《Journal of nursing management》2016,24(2):271-272
999.
1000.
Alterations of cell cycle regulators in localized synovial sarcoma: A multifactorial study with prognostic implications 下载免费PDF全文
Antonescu CR Leung DH Dudas M Ladanyi M Brennan M Woodruff JM Cordon-Cardo C 《The American journal of pathology》2000,156(3):977-983
Genetic alterations of cell cycle regulators are thought to represent uncommon and possible secondary events in sarcomas characterized by recurrent chromosomal translocations. The present study investigates this hypothesis on synovial sarcoma (SS), assessing the frequency of expression and possible clinical implications of detecting alterations in critical cell cycle regulatory proteins. A homogeneous cohort of 49 patients with localized SS, restricted to the extremity and with available long-term follow-up information, was selected from our files. We focused our study on molecules involved in the G1 checkpoint and G1-S transition, including cyclins D1 and E, p21(WAF1), p27(Kip1), mdm2, p53, and Ki67. A cutoff point of 10% immunoreactive tumor cell nuclei was selected to define a positive phenotype for any given marker, except for Ki67. High Ki67 proliferative index was considered when >/=20% tumor cells displayed nuclear immunoreactivity. Biphasic SS were analyzed, taking into account separately the expression of these proteins in the spindle and glandular components. Disease specific survival was modeled using the Kaplan-Meier method with log rank test and Cox regression. The cohort of patients analyzed included 23 females and 26 males, and the histological type distribution was 35 monophasic and 14 biphasic SS. The median follow-up for survivors was 53 months, with a 5-year disease-specific survival of 63% and a metastatic disease-free survival of 40%. The positive phenotypes identified for the different markers studied were as follows: cyclin D1, 59%; cyclin E, 29%; p21, 51%; p27, 69%; mdm2, 59%; p53, 16%; and Ki67, 59%. We observed that positive p53, cyclin E, and high Ki67 proliferative index were correlated with survival, but only Ki67 and p53 were independent variables for prognostication. The present study suggests that alterations of cell cycle regulators are more common events in SS than originally thought. p53 overexpression could be of use as a marker together with a high Ki67 proliferative index, in identifying a subset of SS patients with increased risk of tumor relapse. 相似文献